Treatment with losartan in kidney transplant recipients with posttransplant erythrocytosis
- 20 September 1999
- journal article
- clinical trial
- Published by Elsevier in Transplantation Proceedings
- Vol. 31 (6) , 2321
- https://doi.org/10.1016/s0041-1345(99)00359-0
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Long-term follow-up of renal transplant recipients treated with losartan for post-transplant erythrosisTransplant International, 1998
- Angiotensin II stimulates proliferation of normal early erythroid progenitors.Journal of Clinical Investigation, 1997
- LOSARTAN, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST, REDUCES HEMATOCRITS IN KIDNEY TRANSPLANT RECIPIENTS WITH POSTTRANSPLANT ERYTHROCYTOSISTransplantation, 1997
- EFFICACY OF CAPTOPRIL ON POSTTRANSPLANT ERYTHROCYTOSISTransplantation, 1994
- Posttransplant Erythrocytosis: An Enigma RevisitedAmerican Journal of Kidney Diseases, 1994
- Effects of Enalapril on Erythrocytosis after Renal TransplantationAnnals of Internal Medicine, 1991
- Postrenal transplant erythrocytosis: A review of 53 patientsKidney International, 1983
- Erythremia after Renal TransplantationNew England Journal of Medicine, 1965